Vincenzo Bronte
Vincenzo Bronte
Verified email at
Cited by
Cited by
Coordinated regulation of myeloid cells by tumours
DI Gabrilovich, S Ostrand-Rosenberg, V Bronte
Nature Reviews Immunology 12 (4), 253-268, 2012
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
V Bronte, S Brandau, SH Chen, MP Colombo, AB Frey, TF Greten, ...
Nature communications 7 (1), 12150, 2016
Regulation of immune responses by L-arginine metabolism
V Bronte, P Zanovello
Nature Reviews Immunology 5 (8), 641-654, 2005
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
MZ Noman, G Desantis, B Janji, M Hasmim, S Karray, P Dessen, V Bronte, ...
Journal of Experimental Medicine 211 (5), 781-790, 2014
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
S Walter, T Weinschenk, A Stenzl, R Zdrojowy, A Pluzanska, C Szczylik, ...
Nature medicine 18 (8), 1254-1261, 2012
Altered macrophage differentiation and immune dysfunction in tumor development
A Sica, V Bronte
The Journal of clinical investigation 117 (5), 1155-1166, 2007
The spleen in local and systemic regulation of immunity
V Bronte, MJ Pittet
Immunity 39 (5), 806-818, 2013
The terminology issue for myeloid-derived suppressor cells
DI Gabrilovich, V Bronte, SH Chen, MP Colombo, A Ochoa, ...
Cancer research 67 (1), 425-425, 2007
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
G Gallina, L Dolcetti, P Serafini, C De Santo, I Marigo, MP Colombo, ...
The Journal of clinical investigation 116 (10), 2777-2790, 2006
Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor
I Marigo, E Bosio, S Solito, C Mesa, A Fernandez, L Dolcetti, S Ugel, ...
Immunity 32 (6), 790-802, 2010
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini, I Borrello, V Bronte
Seminars in cancer biology 16 (1), 53-65, 2006
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
P Serafini, K Meckel, M Kelso, K Noonan, J Califano, W Koch, L Dolcetti, ...
The Journal of experimental medicine 203 (12), 2691-2702, 2006
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism
A Mazzoni, V Bronte, A Visintin, JH Spitzer, E Apolloni, P Serafini, ...
The Journal of Immunology 168 (2), 689-695, 2002
Myeloid-derived suppressor cell heterogeneity and subset definition
E Peranzoni, S Zilio, I Marigo, L Dolcetti, P Zanovello, S Mandruzzato, ...
Current opinion in immunology 22 (2), 238-244, 2010
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
I Marigo, L Dolcetti, P Serafini, P Zanovello, V Bronte
Immunological reviews 222 (1), 162-179, 2008
L-arginine metabolism in myeloid cells controls T-lymphocyte functions
V Bronte, P Serafini, A Mazzoni, DM Segal, P Zanovello
Trends in immunology 24 (6), 301-305, 2003
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
B Molon, S Ugel, F Del Pozzo, C Soldani, S Zilio, D Avella, A De Palma, ...
Journal of Experimental Medicine 208 (10), 1949-1962, 2011
Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF
L Dolcetti, E Peranzoni, S Ugel, I Marigo, A Fernandez Gomez, C Mesa, ...
European journal of immunology 40 (1), 22-35, 2010
Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells
V Bronte, E Apolloni, A Cabrelle, R Ronca, P Serafini, P Zamboni, ...
Blood, The Journal of the American Society of Hematology 96 (12), 3838-3846, 2000
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice
V Bronte, P Serafini, C De Santo, I Marigo, V Tosello, A Mazzoni, ...
The Journal of Immunology 170 (1), 270-278, 2003
The system can't perform the operation now. Try again later.
Articles 1–20